Endpoints News Nov 24, 2025 Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials #Novo Nordisk #closely-watched Alzheimer
BioPharma Dive Nov 24, 2025 Bayer’s experimental blood-thinner notches trial win in stroke prevention #Asundexian Phase #prevention Asundexian
Roche Media Nov 24, 2025 Roche Adopts Veeva Vault CRM and Agentic AI in Global Rollout (NYSE: VEEV) - Stock Titan #Global Rollout #Stock Titan
Roche Media Nov 24, 2025 Veeva Announces Expanded Partnership with Roche - PR Newswire #Announces Expanded #Expanded Partnership
Endpoints News Nov 24, 2025 Craig Crews, Mikael Dolsten raise $32M for Quarry Thera #Mikael Dolsten #Quarry Thera
BioWorld Nov 24, 2025 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed
BioWorld Nov 24, 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld Nov 24, 2025 Data back spinal injury bid from Nervgen in phase Ib/IIa #Pharma Corp #Nervgen Pharma
BioPharma Dive Nov 24, 2025 Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies #Novo Nordisk #watched Alzheimer
Thermo Fisher Nov 24, 2025 Thermo Fisher (NYSE:TMO) Shares Edge Higher on Sector Activity - Kalkine Media #Shares Edge #Edge Higher
BioPharma Dive Nov 24, 2025 FDA probes effects of Takeda rare disease drug after patient death #FDA probes #Takeda rare
Agilent Nov 24, 2025 Earnings Scheduled For November 24, 2025 - Benzinga #Earnings Scheduled #Benzinga Earnings